Oncology Venture receives guarantees and undertakings for a proposed rights issue

    NEXT STORY
    Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
    PREV STORY
    European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance

    Stealth start-up company debuts with support from NIH and Leading Immuno-Oncology ExpertsHOUSTON, June 19, ...

    author_avatar
    NASDAQ Market News

    Philips highlights its expanding enterprise imaging informatics portfolio at RSNA 2020

    author_avatar
    NASDAQ Market News

    Cynata Announces Ethics Approval and Expedited Regulatory Pathway for Phase 3 Osteoarthritis Clinical Trial

    author_avatar
    NASDAQ Market News